Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigations

A Hepatic Dose-Toxicity Model Opening the Way Toward Individualized Radioembolization Planning

Stephan Walrand, Michel Hesse, Francois Jamar and Renaud Lhommel
Journal of Nuclear Medicine August 2014, 55 (8) 1317-1322; DOI: https://doi.org/10.2967/jnumed.113.135301
Stephan Walrand
Nuclear Medicine, Molecular Imaging, Radiotherapy, and Oncology Unit (MIRO), IECR, Université Catholique de Louvain, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Hesse
Nuclear Medicine, Molecular Imaging, Radiotherapy, and Oncology Unit (MIRO), IECR, Université Catholique de Louvain, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francois Jamar
Nuclear Medicine, Molecular Imaging, Radiotherapy, and Oncology Unit (MIRO), IECR, Université Catholique de Louvain, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renaud Lhommel
Nuclear Medicine, Molecular Imaging, Radiotherapy, and Oncology Unit (MIRO), IECR, Université Catholique de Louvain, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    NTCP computation scheme. (Top) NTCP computation using simulated lobule dose distribution obtained from synthetic arterial tree. (Bottom) Potential individualization of lobule dose distribution derived from difference between simulated and patient voxel 90Y biodistribution. 90Y biodistribution was computed from synthetic arterial tree convolved with PET resolution to allow its comparison with typical 90Y time-of-flight PET imaging of patient after glass microsphere radioembolization not crossing tumors (both for delivered dose of 120 Gy to liver).

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Lobule radiosensitivity hierarchy model. (Left) Schematic representation of lobule. (Courtesy of Educational Resource Center, College of Veterinary Medicine at University of Georgia; art by Will McAbee.) Because hexagon side-to-side distance is about 1,200 μm, almost all lobule structures are closer than 500 μm from small arteriole or venule (highlighted in red) still transporting blood from only surviving triad (right one). (Right) Lobule is assumed to be serial tissue regarding portal triads, hepatic cells, and centrilobular vein subsets, whereas each subset is assumed to be parallel tissue regarding their respective subunits.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Microscale dose distributions. (A) Total lobule fraction as function of BED delivered to hepatocytes and centrilobular vein subsets. (B) Total lobule fraction as function of BED of less irradiated portal triad. Lobule dose distributions were derived from resin and glass microsphere transport dynamics in synthetically grown hepatic arterial tree (8) for constant number (2.9) of portal arteries in 81% of triads (C) and for several portal arteries per triad following Poisson law of 2.4 mean (P). Distributions were computed for predicted TD50 in two-thirds liver radioembolization (Table 1). Similar lobule dose distributions are obtained for the 2 radioembolization devices regarding less irradiated portal triad (B).

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Comparison of observed and predicted liver NTCP. Shown are Lyman–Burman Kutcher fit (red line) of NTCP observed in SPECT/CT dosimetry clinical study (asterisks) mixing whole-liver (35 patients), right-lobe (35 patients), and left-lobe (3 patients) resin radioembolization; SD (vertical bars); 95% confidence interval (dashed line); liver absorbed dose (D); predicted NTCP in whole-liver and two-thirds liver resin radioembolization (RE) computed using new radiobiologic model (black lines); and predicted NTCP accounting for proportion of whole-liver, right-lobe, and left-lobe RE present in each observed point (circles). (Data are from Strigari et al. (3) and from written communication with Strigari, October 2013). CI = confidence interval.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    TD50 as function of targeted liver volume fraction Vf for different microsphere activities computed using radiobiologic model. Circles are Monte Carlo simulations. Curves are fit using Equation 8. Red and blue colors correspond to glass and resin microspheres, respectively, at day of calibration. Purple color corresponds to glass microspheres used 8 d after calibration. Diamond is TD50 observed in right-lobar radioembolization using glass microspheres (4). Square is TD50 observed in mixing of right-lobar and whole-liver radioembolization using resin microspheres (3).

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1

    Observed and Predicted Doses (Gy) Giving NTCP of 0.5 for Different Irradiation Modalities

    Clinical studiesEUDKB50 (11)EUDJH50 (12)Predicted TD50 (this work)
    Modality and liver fractionObserved TD50Observed BED50
    EBRT 1/143 (5)77777743
    EBRT 4/553 (5)95777052
    EBRT 2/364 (5)115786664
    Resin 1/1 + 2/352* (3)932397855
    Glass 2/3100 (4)2524337799
    • ↵* Mixed whole-liver and right-lobe radioembolization.

Additional Files

  • Figures
  • Tables
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 55 (8)
Journal of Nuclear Medicine
Vol. 55, Issue 8
August 1, 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Hepatic Dose-Toxicity Model Opening the Way Toward Individualized Radioembolization Planning
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
A Hepatic Dose-Toxicity Model Opening the Way Toward Individualized Radioembolization Planning
Stephan Walrand, Michel Hesse, Francois Jamar, Renaud Lhommel
Journal of Nuclear Medicine Aug 2014, 55 (8) 1317-1322; DOI: 10.2967/jnumed.113.135301

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Hepatic Dose-Toxicity Model Opening the Way Toward Individualized Radioembolization Planning
Stephan Walrand, Michel Hesse, Francois Jamar, Renaud Lhommel
Journal of Nuclear Medicine Aug 2014, 55 (8) 1317-1322; DOI: 10.2967/jnumed.113.135301
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
Show more Basic Science Investigations

Similar Articles

Keywords

  • radioembolization
  • PET
  • dosimetry
  • normal tissue complication probability
  • Monte Carlo
SNMMI

© 2025 SNMMI

Powered by HighWire